Drug Manufacturers - General2 months ago
Kopran Limited Q1 FY 2026-27: Corporate Presentation Unveils Financial and Operational Insights
Kopran Limited (NSE: KOPRAN) Q1 FY 2026-27 results: financial highlights, operational performance, and strategic outlook.